Kezar Life Sciences (KZR) Earnings Date, Estimates & Call Transcripts $0.57 0.00 (0.00%) (As of 09/13/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateNov. 11EstimatedActual EPS (Aug. 13) -$0.28 Beat By $0.04 Consensus EPS (Aug. 13) -$0.32 Get Kezar Life Sciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for KZR and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueKZR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.KZR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaThe #1 Altcoin for September 2024With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Now, I'm about to reveal the #1 crypto for September 2024. Go here to get full details on this crypto now. Kezar Life Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.34)($0.28)($0.31)Q2 20242($0.27)($0.26)($0.27)Q3 20242($0.30)($0.24)($0.27)Q4 20242($0.37)($0.17)($0.27)FY 20248($1.28)($0.95)($1.12)Q1 20252($0.35)($0.22)($0.29)Q2 20251($0.35)($0.35)($0.35)Q3 20252($0.36)($0.20)($0.28)Q4 20252($0.36)($0.19)($0.28)FY 20257($1.42)($0.96)($1.19)KZR Earnings Date and InformationKezar Life Sciences last posted its earnings results on August 13th, 2024. The reported ($0.28) earnings per share for the quarter, topping the consensus estimate of ($0.32) by $0.04. Kezar Life Sciences has generated ($1.40) earnings per share over the last year (($1.40) diluted earnings per share). Earnings for Kezar Life Sciences are expected to grow in the coming year, from ($1.20) to ($1.17) per share. Kezar Life Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off prior year's report dates.Read More Kezar Life Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/11/2024(Estimated)------- 8/13/2024Q2 2024($0.32)($0.28)+$0.04($0.26)--5/9/2024Q1 2024($0.34)($0.30)+$0.04($0.30)--3/14/2024Q4 2023($0.39)($0.35)+$0.04($0.26)--11/13/2023Q3 2023($0.36)($0.32)+$0.04($0.32)$0.50 million$7.00 million8/10/2023Q2 2023($0.33)($0.34)($0.01)($0.34)--5/11/2023Q1 2023($0.28)($0.31)($0.03)($0.31)-- Get the Latest News and Ratings for KZR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kezar Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 3/14/2023Q4 2022($0.24)($0.25)($0.01)($0.25)--11/10/2022Q3 2022($0.26)($0.25)+$0.01($0.25)--8/11/2022Q2 2022($0.27)($0.25)+$0.02($0.25)--5/12/2022Q1 2022($0.29)($0.26)+$0.03($0.26)-- 3/17/2022Q4 2021($0.29)($0.25)+$0.04($0.25)--11/9/2021Q3 2021($0.26)($0.28)($0.02)($0.28)--8/12/2021Q2 2021($0.26)($0.25)+$0.01($0.25)--5/12/2021Q1 2021($0.24)($0.25)($0.01)($0.25)--3/11/2021Q4 2020($0.23)($0.22)+$0.01($0.22)--11/5/2020Q3 2020($0.21)($0.23)($0.02)($0.23)-- 8/5/2020Q2 2020($0.26)($0.22)+$0.04($0.22)-- 5/7/2020Q1 2020($0.3740)($0.30)+$0.0740($0.30)--3/12/2020Q4 2019($0.5450)($0.5009)+$0.0441($0.50)--11/6/2019Q3($0.5140)($0.48)+$0.0340($0.48)-- Kezar Life Sciences Earnings - Frequently Asked Questions When is Kezar Life Sciences's earnings date? Kezar Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates. Learn more on KZR's earnings history. Did Kezar Life Sciences beat their earnings estimates last quarter? In the previous quarter, Kezar Life Sciences (NASDAQ:KZR) reported ($0.28) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.32) by $0.04. Learn more on analysts' earnings estimate vs. KZR's actual earnings. How much revenue does Kezar Life Sciences generate each year? Kezar Life Sciences (NASDAQ:KZR) has a recorded annual revenue of $7 million. How much profit does Kezar Life Sciences generate each year? Kezar Life Sciences (NASDAQ:KZR) has a recorded net income of -$101.87 million. KZR has generated -$1.40 earnings per share over the last four quarters. What is Kezar Life Sciences's EPS forecast for next year? Kezar Life Sciences's earnings are expected to grow from ($1.20) per share to ($1.17) per share in the next year. More Earnings Resources from MarketBeat Related Companies: NextCure Earnings Hookipa Pharma Earnings Zura Bio Earnings Vaxart Earnings MediWound Earnings FitLife Brands Earnings Galectin Therapeutics Earnings Ventyx Biosciences Earnings Telomir Pharmaceuticals Earnings BioVie Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:KZR) was last updated on 9/15/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election M...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWhy Institutions Are Bullish on BitcoinThe recent dip in the crypto market might be stressful… But it also presents a tremendous opportunity for s...Crypto 101 Media | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kezar Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kezar Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
